Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05205252
Title Multi Cohort Study of Tazemetostat in Combination With Various Treatments For R/R Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Epizyme, Inc.

mantle cell lymphoma

diffuse large B-cell lymphoma

multiple myeloma


Lenalidomide + Tafasitamab-cxix + Tazemetostat

Daratumumab + Dexamethasone + Pomalidomide + Tazemetostat

Daratumumab and hyaluronidase-fihj + Dexamethasone + Pomalidomide + Tazemetostat

Lenalidomide + Tazemetostat

Acalabrutinib + Tazemetostat

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.